Life Sciences Nova Scotia Shares Leadership Transition News

by | May 21, 2024 | News

Date: May 21, 2024

Halifax, Nova Scotia, May 21, 2024 – Life Sciences Nova Scotia (LSNS) has announced that Sean Awalt will be stepping down from his role as Chief Executive Officer (CEO) on May 21, 2024, to pursue a new opportunity in industry. The LSNS Board of Directors has named Doris Grant, the current Vice President of Business Development and Strategy, as his successor, also effective May 21, 2024.

Kevin Sullivan, Chair of the LSNS Board of Directors, expressed heartfelt gratitude for Mr. Awalt’s contributions during his tenure: “Sean Awalt has played a pivotal role in advancing LSNS’s mission and fostering growth in the life sciences sector in Nova Scotia. His expertise and leadership have been invaluable in shaping our organization and its strategic direction.”

Doris Grant brings a wealth of experience from her 25 years in industry, academia, and the health system. In her new role as CEO, she will draw on this extensive background to guide LSNS into its next phase of growth. She has been instrumental in building impactful partnerships and possesses a deep understanding of the life sciences sector.

“Doris Grant’s appointment as CEO marks an exciting new chapter for LSNS,” stated Kevin Sullivan. “Her leadership skills, industry knowledge and experience, and commitment to innovation will be crucial as we continue to support the acceleration of the life sciences sector in Nova Scotia.”

Expressing her enthusiasm, Doris Grant said, “I am honored to lead LSNS and build upon the strong foundation established by Sean Awalt. Together with our dedicated team and members, we will continue to drive innovation, foster collaboration, and promote economic growth in Nova Scotia’s vibrant life sciences community.”

For more information, visit

About Doris Grant: Doris embarked on her career in the biopharmaceutical industry, specializing in business development, before transitioning to Dalhousie University, where she led the commercialization of health and life sciences technologies. Her tenure included instrumental roles in the inception of multiple startup companies in Nova Scotia. Later, as the inaugural Senior Director of Innovation at Nova Scotia Health, Doris forged significant partnerships with industry, both locally and globally. In her previous role as VP Business Development, she has collaborated closely with numerous companies, facilitating the acceleration of their commercialization efforts, and spearheading the establishment of new programs and supports to enhance their acceleration journey.  She has both a BSc and MSc from Dalhousie University.

About Life Sciences Nova Scotia: We are a non-profit industry association committed to creating value and prosperity for its members. We provide the support members need while advocating to enhance the Life Sciences ecosystem for sector growth. Together, our members, partners and stakeholders provide a united powerful voice to advance the sector’s interests.  Our Board of Directors and Life Sciences Nova Scotia Team undertake initiatives by request of, and on behalf of, our diverse membership.


Media Contact:

Laurie Ann Coring

Manager, Marketing & Communications

Life Sciences Nova Scotia